LIVN
LivaNova PLC

371
Loading...
Loading...
News
all
press releases
Nyxoah Expands in the Middle East to Provide Wider Access to Genio
NYXH expands in the Middle East after Abu Dhabi's first Genio implant, aiming to broaden access for OSA patients.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Should Value Investors Buy LivaNova (LIVN) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·3d ago
News Placeholder
LivaNova PLC (LIVN) Soars to 52-Week High, Time to Cash Out?
LivaNova (LIVN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks·25d ago
News Placeholder
Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea
NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.
Zacks·2mo ago
News Placeholder
LivaNova (LIVN) Q2 Earnings and Revenues Beat Estimates
LivaNova (LIVN) delivered earnings and revenue surprises of +25.00% and +6.56%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Avanos Medical (AVNS) Misses Q2 Earnings Estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of -5.56% and +4.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Are Options Traders Betting on a Big Move in LivaNova Stock?
Investors need to pay close attention to LivaNova stock based on the movements in the options market lately.
Zacks·3mo ago
News Placeholder
LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported fourth-quarter and full-year 2024 results and issued full-year 2025 guidance. Financial Summary and...
Business Wire·7mo ago
News Placeholder
LivaNova to Present at the Barclays Global Healthcare Conference
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Barclays Global...
Business Wire·7mo ago
News Placeholder
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2024 results on Tuesday, February 25, 2025 at 1 p.m...
Business Wire·9mo ago

Latest LIVN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.